TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
BDSX

Biodesix Inc

Healthcare · Diagnostics & Research

29.80$ +2.2% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow BDSX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-86.5% -88.5% -46.9% -51.8% -117.7% -46.6% -68.2% -26.3%
8.5% 11.4% 6.4% 5.8% 15.3% 11.2% 7.6% 6.3%
0.7% 0.7% 8.1% 9.1% 15.6% 10.9% 9.3% 4.7%
31.3% 30.3% 16.1% 13.1% 49.7% – – –
1.2% -6.7% -10.5% 8.4% -11.4% 23.0% -30.4% 0.4%
3.0% 5.3% 4.8% 4.7% 9.2% 47.0% 4.5% 0.5%
-3.0% -7.6% -6.4% -4.7% -9.2% -47.0% -4.8% -0.5%
– – – 0.6% – 1.3% – –
– – – 0.6% 0.9% 1.3% 0.9% 0.6%
52.7% 53.1% 35.2% -28.5% 43.2% 20.3% -0.1% 11.3%
93.1% 93.6% 178.1% 2.3% 154.1% 59.3% 73.0% 18.6%
3.6% -2.6% 124.8% -54.1% 27.2% -34.2% -0.1% -8.2%
-89.5% -93.8% -51.7% -56.5% -126.9% -93.6% -72.7% -26.8%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?